[1]袁维,龚志强,王炳予,等.基于粪便和肝脏胆汁酸代谢网络分析芪参汤对肝纤维化小鼠的影响[J].中国中医药信息杂志,2021,28(10):86-92.[doi:10.19879/j.cnki.1005-5304.202101114]
 YUAN Wei,GONG Zhiqiang,WANG Bingyu,et al.Effects of Qishen Decoction on Mice with Liver Fibrosis Through Fecal and Liver Bile Acid Metabolic Network[J].zhongguo zhongyiyao xinxi zazhi,2021,28(10):86-92.[doi:10.19879/j.cnki.1005-5304.202101114]
点击复制

基于粪便和肝脏胆汁酸代谢网络分析芪参汤对肝纤维化小鼠的影响

参考文献/References:

[1] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.肝纤维化诊断及治疗共识(2019年)[J].临床肝胆病杂志, 2019,35(10):2163-2172.

[2] 李硕熙,王炳予,杨磊,等.芪参汤通过PI3K/Akt/mTOR信号通路抗肝纤维化的机制研究[J].海南医学院学报,2020,26(12):905-909,914.

[3] 王炳予,张雅丽,杨磊,等.基于16S rRNA技术探讨芪参汤治疗非酒精性脂肪性肝纤维化的作用机制[J].海南医学院学报,2020,26(1):18-24.

[4] 杜桂芳,董金珂,张婷,等.Fyn与小鼠肝纤维化模型中胆汁酸代谢组分的相关性研究[J].传染病信息,2018,31(4):326-330.

[5] ARAB J P, KARPEN S J, DAWSON P A, et al. Bile acids and nonalcoholic fatty liver disease:molecular insights and therapeutic perspectives[J]. Hepatology,2017,65(1):350-362.

[6] CHOW M D, LEE Y H, GUO G L. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Mol Aspects Med,2017,56:34-44.

[7] 孙梦园,向晓星.肠道菌群和胆汁酸通路在非酒精性脂肪性肝病发病中的作用[J].临床肝胆病杂志,2020,36(12):2831-2834.

[8] 龚彤,陈国芳,刘超.肠道菌群——胆汁酸通路对代谢性疾病的影响[J].中国糖尿病杂志,2019,27(12):953-955.

[9] 贺争鸣,李根平,朱德生,等.实验动物管理与使用指南[M].北京:科学出版社,2016:142-150.

[10] 刘洋,宋海燕,舒祥兵,等.降脂颗粒改善蛋氨酸-胆碱缺乏饮食诱导的非酒精性脂肪性肝炎的小鼠肝纤维化[J].中华中医药杂志,2015, 30(9):3321-3325.

[11] MA C, HAN M J, HEINRICH B, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells[J]. Science, 2018,360(6391):eaan5931.

[12] PURI P, DAITA K, JOYCE A, et al. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids[J]. Hepatology,2018,67(2):534-548.

[13] 欧强,杨华,赵亚娟,等.蛋氨酸-胆碱缺乏饮食诱导的大、小鼠非酒精性脂肪性肝病模型的特点及差异[J].肝脏,2017,22(10):933-937.

[14] 徐叶进,唐新月,杨敏,等.白细胞介素10基因修饰的树突状细胞对肝纤维化小鼠的治疗作用及其机制[J].中华内科杂志,2018,57(11):835-840.

[15] YUAN X X, GONG Z Q, WANG B Y, et al. Astragaloside inhibits hepatic fibrosis by modulation of TGF-β1/Smad signaling pathway[J]. Evid Based Complement Alternat Med,2018,2018:3231647.

[16] QIN L F, QIN J M, ZHEN X M, et al. Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis:a study in vitro and in vivo[J]. Biomed Pharmacother,2018,101:599-607.

[17] QIN L F, QIN J M, ZHANG J Q, et al. CXCL12 and CXCR4 polymorphisms and expressions in peripheral blood from patients of hepatocellular carcinoma[J]. Future Oncol,2018,14(13):1261-1271.

相似文献/References:

[1]李珊,蔡锐,伍参荣.加味四逆散对血吸虫病小鼠肝纤维化相关因子表达的影响[J].中国中医药信息杂志,2011,18(2):41.[doi:10.3969/j.issn.1005-5304.2011.02.017]
 LI Shan,CAI Rui,WU Can-rong.Effect of Modified Sini Powder on Expression of Liver Fibrosis Related Factors in Schistosomiasis Mice[J].zhongguo zhongyiyao xinxi zazhi,2011,18(10):41.[doi:10.3969/j.issn.1005-5304.2011.02.017]
[2]郭晓平.双虎清肝颗粒联合苦参素对乙型肝炎病毒感染后肝纤维化指标的干预作用[J].中国中医药信息杂志,2008,15(2):71.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(10):71.
[3]徐波,陆茵,吴家明,等.姜黄素抗肝纤维化分子机制研究进展[J].中国中医药信息杂志,2008,15(3):90.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(10):90.
[4]范荣国,王安莲.苦参素胶囊联合安络化纤丸防治慢性乙型肝炎肝纤维化临床观察[J].中国中医药信息杂志,2008,15(5):71.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(10):71.
[5]姚立,余静,李珏.丹参软肝饮对肝纤维化大鼠肝功能及肾素-血管紧张素-醛固酮系统的影响[J].中国中医药信息杂志,2011,18(4):34.[doi:10.3969/j.issn.1005-5304.2011.04.014]
 YAO Li,YU Jing,LI Jue.Influence of Danshen Ruangan Yin on Liver Fibrosis and RAAS of Rats[J].zhongguo zhongyiyao xinxi zazhi,2011,18(10):34.[doi:10.3969/j.issn.1005-5304.2011.04.014]
[6]刘江凯.百令胶囊治疗肝炎后肝纤维化临床观察[J].中国中医药信息杂志,2011,18(10):76.[doi:10.3969/j.issn.1005-5304.2011.10.033]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(10):76.[doi:10.3969/j.issn.1005-5304.2011.10.033]
[7]李晓杰,车景超.中药抗肝纤维化研究进展[J].中国中医药信息杂志,2007,14(9):94.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(10):94.
[8]张秋云,刘绍能,李媛娥.从痰论治肝纤维化探讨[J].中国中医药信息杂志,2007,14(11):86.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(10):86.
[9]李亮,缪英年,月辰,等.平肝汤抗大鼠肝纤维化的实验研究[J].中国中医药信息杂志,2005,12(4):27.
 LI Liang,Miao Ying-nian,YUE Cheng,et al.Experimental Study on the Effects of Pinggan Tang on Liver Fibrosis[J].zhongguo zhongyiyao xinxi zazhi,2005,12(10):27.
[10]徐国良.中西医结合治疗慢性乙型肝炎肝纤维化36例[J].中国中医药信息杂志,2006,13(2):57.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(10):57.
[11]袁维,王炳予,杨磊,等.芪参汤对肝纤维化大鼠肝组织辅助性T细胞17/调节性T细胞平衡的影响[J].中国中医药信息杂志,2021,28(8):66.[doi:10.19879/j.cnki.1005-5304.202012333]
 YUAN Wei,WANG Bingyu,YANG Lei,et al. Effects of Qishen Decoction on Th17/Treg Cell Balance in Rats with Liver Fibrosis[J].zhongguo zhongyiyao xinxi zazhi,2021,28(10):66.[doi:10.19879/j.cnki.1005-5304.202012333]

备注/Memo

基金项目:国家自然科学基金青年基金(81904182);湖南省卫生计生委科研计划项目(20200752);湖南省自然科学基金(2020JJ5441);黑龙江省中医药科研项目(ZHY18-029、ZHY19-061、ZHY19-062、ZHY2020-041);黑龙江省自然科学基金联合引导项目(LH2019H095)

更新日期/Last Update:

2021-09-22